Your browser doesn't support javascript.
loading
OCT4 is expressed in extraembryonic endoderm stem (XEN) cell progenitors during somatic cell reprogramming.
Moauro, Alexandra; Hickey, Stephanie L; Halbisen, Michael A; Parenti, Anthony; Ralston, Amy.
Afiliação
  • Moauro A; Molecular, Cellular and Integrative Physiology Ph.D. Program, Michigan State University, East Lansing, MI, 48824.
  • Hickey SL; D.O.-Ph.D. Program, Michigan State University, East Lansing, MI, 48824.
  • Halbisen MA; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, 48824.
  • Parenti A; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, 48824.
  • Ralston A; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, 48824.
bioRxiv ; 2024 Jan 22.
Article em En | MEDLINE | ID: mdl-38328220
ABSTRACT
During development, progenitors of embryonic stem (ES) and extraembryonic endoderm stem (XEN) cells are concomitantly specified within the inner cell mass (ICM) of the mouse blastocyst. Similarly, XEN cells are induced (iXEN cells) alongside induced pluripotent stem (iPS) cells following overexpression of Oct4, Sox2, Klf4 and Myc (OSKM) during somatic cell reprogramming. It is unclear how or why this cocktail produces both stem cell types, but OCT4 has been associated with non-pluripotent outcomes. In this report, we show that, during OSKM reprogramming, many individual Oct4-GFP-expressing cells are fated to become iXEN cells. Interestingly, SKM alone was also sufficient to induce iXEN cell formation, likely via activation of endogenous Oct4. These observations indicate that iXEN cell formation is not strictly an artifact of Oct4 overexpression. Moreover, our results suggest that a pathway to XEN may be an integral feature of establishing pluripotency during reprogramming, as in early embryo development.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos